R&D to Manufacturing Leverage the recent AIDDISON SaaS launch and Synthia API integration to offer end-to-end digital drug discovery workflows, integrating with ChemisTwin for reproducible analytics and data flow between virtual design and real-world manufacturing.

Biologics Growth The €50M antibody production facility expansion in France signals a biologics growth trajectory; target European biopharma and contract manufacturers with antibodies, cell culture media, purification resins, and QA/QC reagents.

Startup Partnerships EMD Millipore's history with LabCentral and a midsize workforce suggests strong alignment with early-stage labs; propose starter programs, pilot kits, and bundled reagent/software packages to convert startups into long-term customers.

Global Expansion With Merck KGaA backing and recent European investments, pursue cross-border sales in pharma, cosmetics, and food sectors requiring high-purity chemicals, reference standards, and digital analytics platforms.

Digital Transformation Capitalize on digital platform momentum by upselling data management, reference material analytics, and API-enabled workflows to labs seeking reproducibility, regulatory readiness, and integrated lab operations.